Written by
Share article:
Komodo Health has unveiled new generative AI capabilities within its MapLab platform, in order to simplify healthcare analytics problems, and to uncover strategic Insights to improve decision making.
The tools should facilitate the better utilisation of de-identified patient-level insights and help improve workflows and offer better analysis to inform decision making.
Why we have chosen this topic
– One of the key early uses of generative AI will be in improving analytics
– Komodo’s customer base, which includes large influential vendors such as Johnson & Johnson, Merck and Novo Nordisk means the new offering could have a notable impact on the market
Why it matters
– Komodo Health has opted to use an open source model to power its generative AI capabilities, this could hint at vendors’ feelings to the advantages of different models
– Komodo says the new offering will offer insights across 330 million patient journeys, a figure highlighting how impactful successful (or unsuccessful) solutions may be
– Better managing patient workflows and the prevalence of some diseases will bring significant advantages to many providers
